

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Trastuzumab-pkrb ni umuti w'indwara ya kanseri ugamije gufasha kuvura ubwoko bumwe bwa kanseri y'ibere n'iy'igifu. Ni icyo abaganga bita umubiri w'umuntu umwe, bivuze ko yagenewe gushaka no kwifatanya na poroteyine zihariye ku ngirangingo za kanseri kugira ngo zifashe kuzihagarika gukura.
Uyu muti utangwa unyuze mu muyoboro w'amaraso mu kuboko kwawe ku bitaro cyangwa ahantu ho guterwa imiti. Itsinda ry'abaganga bazagufasha muri ubu buryo bwose, bakemeza ko wumva umeze neza kandi ufite amakuru ahagije mu ntambwe zose.
Trastuzumab-pkrb ni verisiyo ya biosimilar y'umuti wa mbere wa trastuzumab. Tekereza nk'igikopi gisa cyane gikora kimwe ariko gihendutse kurusha umuti w'izina ry'umwimerere.
Uyu muti ubarirwa mu itsinda ryitwa HER2-targeted therapies. Ukora ubu ukoresha guhagarika poroteyine yitwa HER2, ingirangingo zimwe za kanseri zikoresha kugira ngo zikure kandi zikwirakwire. Hafi 20% bya kanseri y'ibere na kanseri zimwe zo mu gifu zifite iyi poroteyine ya HER2 nyinshi.
Uyu muti uza mu ifu itsinda ry'abaganga rivanga n'amazi atagira mikorobe mbere yo kuyiguha unyuze mu muyoboro w'amaraso. Uzayihabwa ahantu h'ubuvuzi aho abantu bafite ubumenyi bazagukurikiranira hafi.
Trastuzumab-pkrb ivura kanseri y'ibere ya HER2-positive na kanseri y'igifu ya HER2-positive. Muganga wawe azagerageza ingirangingo zawe za kanseri kugira ngo yemeze ko zifite poroteyine ya HER2 mbere yo gutangira ubu buvuzi.
Ku bijyanye na kanseri y'ibere, abaganga bakoresha uyu muti mu bihe bitandukanye. Irashobora gufasha kugabanya ibibyimba mbere yo kubagwa, gukumira kanseri kugaruka nyuma yo kubagwa, cyangwa kuvura kanseri yageze mu bindi bice by'umubiri wawe.
Ku bijyanye na kanseri y'igifu, uyu muti akenshi ukoreshwa iyo kanseri yageze ahandi kandi idashobora gukurwaho no kubagwa. Akenshi itangwa hamwe na chemotherapy kugira ngo ifashe gukora neza ubuvuzi.
Trastuzumab-pkrb ikora yibanda kuri poroteyine ya HER2 ku ngirangingo za kanseri. Yifatanya kuri iyi poroteyine nk'urufunguzo rwinjira mu gikingi, ibi bikabuza ingirangingo za kanseri kwakira ibimenyetso bibabwira gukura no kwigabanya.
Ibi bifatwa nk'umuti wa kanseri ukomeye mu rugero rwo hagati wibanda by'umwihariko ku ngirangingo za kanseri aho kugira ngo ugire ingaruka ku ngirangingo zose zigabanyuka vuba mu mubiri wawe. Ubu buryo bwihariye akenshi busobanura ingaruka nke ugereranyije na shimiotherapi ya gakondo.
Uyu muti unafasha urwego rwawe rw'ubudahangarwa kumenya no kurwanya ingirangingo za kanseri neza kurushaho. Mu by'ukuri, urashyira ibimenyetso ku ngirangingo za kanseri kugira ngo ubwirinzi bw'umubiri wawe busanzwe bushobore kuzibona no kuzirimbura byoroshye.
Uzahabwa trastuzumab-pkrb nk'urukingo rwinjizwa mu maraso mu bitaro cyangwa ikigo kivura kanseri. Uyu muti utangwa unyuze mu tuyunguruzo duto dushyizwe mu urukururuko rwawe cyangwa unyuze muri port niba ufite imwe.
Urukingo rwawe rwa mbere ruzatwara iminota nka 90, kandi ikipe yawe y'ubuzima izakureba neza niba hari icyo byagutera. Niba wihanganira urukingo rwa mbere neza, urukingo ruzaza akenshi rutwara iminota 30.
Ntabwo ukeneye kurya cyangwa kunywa ikintu cyihariye mbere yo guhabwa urukingo. Ariko, ni byiza kuguma ufite amazi ahagije kandi ukarya ifunguro rito mbere yuko urukingo rutangira kuko kuvurwa bishobora gutwara amasaha make harimo n'igihe cyo gutegura.
Igihe cyo kuvurwa giterwa n'uko ubuzima bwawe buhagaze n'uburyo wihanganira umuti. Ku kanseri y'ibere yo mu ntangiriro, kuvurwa akenshi bifata umwaka umwe hamwe n'inkingo buri byumweru bitatu.
Ku kanseri yateye imbere cyangwa yimukiye ahandi, ushobora gukomeza kuvurwa igihe cyose bifasha kugenzura kanseri yawe kandi ukaba uyihanganira neza. Muganga wawe azakurikiza uko urimo utera imbere akoresheje isesengura risanzwe n'ibizamini by'amaraso.
Ntugasize gufata uyu muti utabanje kuvugana na muganga wawe, kabone n'iyo wumva umeze neza. Itsinda ryawe rishinzwe ubuzima rizafata icyemezo cy'igihe cyiza cyo guhagarika gishingiye ku buryo wabyakiriyeho n'ubuzima bwawe muri rusange.
Kimwe n'imiti yose, trastuzumab-pkrb ishobora gutera ibikorwa bigaragara, nubwo abantu benshi bayihanganira neza. Ikintu cy'ingenzi cyo kumenya ni uko itsinda ryawe rishinzwe ubuzima rizagukurikiranira hafi kandi rifashe mu gukemura ibibazo byose byavuka.
Dore ibikorwa bigaragara bisanzwe ushobora guhura nabyo mugihe uvurwa:
Ibi bikorwa bigaragara mubisanzwe birashoboka kandi akenshi birakosoka uko umubiri wawe wimenyereza umuti. Itsinda ryawe rishinzwe ubuzima rifite uburyo bwinshi bwo kugufasha kumva umeze neza.
Ibikorwa bigaragara bitari bike ariko bikomeye bisaba ubufasha bwihutirwa bwa muganga. Nubwo ibi bitaba kuri buri wese, ni ngombwa kubimenya:
Muganga wawe azagenzura imikorere y'umutima wawe buri gihe mugihe uvurwa kuko uyu muti rimwe na rimwe ushobora kugira ingaruka ku buryo umutima wawe utera amaraso neza. Ibi bikorwa byo gukurikirana bifasha gufata ibibazo byose hakiri kare mugihe bivurwa cyane.
Trastuzumab-pkrb ntiriboneye kuri buri wese, kandi muganga wawe azasuzuma neza amateka yawe y'ubuzima mbere yo kubigushyiraho. Ikintu cy'ingenzi ni niba ibizamini bya kanseri yawe byerekana ko ufite poroteyine ya HER2.
Ntabwo wagombye guhabwa uyu muti niba waragize allergie ikomeye kuri trastuzumab cyangwa ibindi bice byayo byose mu gihe gishize. Muganga wawe azitonda kandi niba ufite indwara zimwe na zimwe z'umutima cyangwa amateka y'ibibazo by'umutima.
Abantu bafite indwara zikomeye z'ibihaha cyangwa ibibazo byo guhumeka bashobora gukenera gukurikiranwa byihariye cyangwa ntibashobore kuba abakandida beza kuri ubu buvuzi. Muganga wawe azagereranya inyungu n'ibibazo by'ubuzima bwawe bwihariye.
Niba utwite cyangwa uteganya gutwita, uyu muti ushobora kwangiza umwana wawe. Muganga wawe azaganira ku buryo bwo kuboneza urubyaro bwiza n'akamaro ko kwirinda gutwita mugihe cy'ubuvuzi no mumyaka myinshi nyuma yaho.
Trastuzumab-pkrb igurishwa munsi y'izina ry'ubwoko rya Herzuma. Iyi ni verisiyo ya biosimilar ikora kimwe n'umuti wa trastuzumab w'umwimerere witwa Herceptin.
Muganga wawe cyangwa umufarumasiti ashobora gukoresha izina rusange (trastuzumab-pkrb) cyangwa izina ry'ubwoko (Herzuma) mugihe baganira ku buvuzi bwawe. Amazina yombi yerekeza ku muti umwe.
Ubwishingizi bushobora rimwe na rimwe gutandukana hagati y'ubwoko butandukanye bwa trastuzumab, bityo ikipe yawe y'ubuzima izakorana nawe kugirango ubone uburyo buhendutse bukwiye gahunda yawe y'ubuvuzi.
Imiti myinshi irashobora kuvura kanseri ya HER2-positive, kandi muganga wawe azahitamo uburyo bwiza bushingiye ku miterere yawe yihariye. Trastuzumab y'umwimerere (Herceptin) ikora kimwe na trastuzumab-pkrb.
Izindi nshuti zifasha HER2 harimo pertuzumab, akenshi ikoreshwa hamwe na trastuzumab kubera kanseri zimwe na zimwe z'ibere. Hariho kandi T-DM1, ivanga trastuzumab na chimiothérapie mu muti umwe.
Ku bantu bamwe, ibindi byemezo bishya nka tucatinib cyangwa neratinib bishobora kuba bikwiye, cyane cyane niba izindi mvura zitagize icyo zikora. Muganga wawe w'inzobere mu by'ubuvuzi azatekereza ibintu nk'ubuzima bwawe muri rusange, icyiciro cya kanseri yawe, n'imiti wahawe mbere yo kugusaba izindi mvura.
Trastuzumab-pkrb ikora neza nk'uko Herceptin y'umwimerere ikora kuko bita ko ari biosimilar. Ibi bivuze ko byagaragaye ko bisa cyane mu bijyanye n'umutekano n'ubushobozi.
Inyungu nyamukuru ya trastuzumab-pkrb akenshi ni ukugabanya ikiguzi. Biosimilars akenshi agura make kurusha imiti y'umwimerere, ibi bikaba byafasha koroshya uburyo bwo kuvurwa no kugabanya amafaranga akoreshwa mu buvuzi.
Muganga wawe azatekereza ibintu nk'ubwishingizi, uko ihari, n'ibyo ikigo kivuriraho gishaka mu gihe cyo guhitamo hagati y'izi mvura. Imiti yombi izaguha inyungu zimwe zo kurwanya kanseri.
Trastuzumab-pkrb rimwe na rimwe rishobora kugira ingaruka ku mikorere y'umutima, bityo abantu bafite ibibazo by'umutima basanzwe bakeneye gukurikiranwa by'umwihariko. Muganga wawe azagenzura imikorere y'umutima wawe hamwe n'ibizamini nka echocardiogram mbere yo gutangira kuvurwa no mu gihe cyose cyo kuvurwa.
Niba ufite ibibazo by'umutima byoroheje, ushobora kuba ugishobora guhabwa uyu muti hamwe no gukurikiranwa neza. Ariko, abantu bafite umutima udakora neza cyangwa imikorere y'umutima yagabanutse cyane ntibashobora kuba abakandida beza kuri ubu buvuzi.
Kubera ko uyu muti utangwa n'abavuzi b'indwara mu bitaro, kwica urugo ku buryo butunguranye ni gake cyane. Uburyo bwo gutanga imiti burabarwa neza hashingiwe ku gipimo cy'umubiri wawe kandi bitangwa n'abakozi babihuguriwe.
Niba ufite impungenge ku gipimo cyawe cyangwa wumva ibimenyetso bidasanzwe nyuma yo kuvurwa, vugana n'ikipe yawe y'ubuvuzi ako kanya. Bashobora gusuzuma uko umeze kandi bakaguha ubufasha bukwiye niba bibaye ngombwa.
Niba wacikanwe n'urugero rwawe rwateganyijwe, vugana n'ikipe yawe y'ubuvuzi vuba bishoboka kugira ngo uteganyirize urugero rushya. Ni ngombwa gukurikiza gahunda yawe yo kuvurwa uko bishoboka kose kugira ngo ugere ku musaruro mwiza.
Muganga wawe azakugira inama y'uko wahindura gahunda yawe yo kuvurwa niba hari impinduka zikenewe ku gipimo cyawe. Ntukagerageze gusimbura urugero wacikanwe n'urugero rwo guteganya imiti yegereye cyane.
Ntuzigere ureka gufata trastuzumab-pkrb utabanje kubiganiraho na muganga wawe. Umwanzuro wo kureka biterwa n'ibintu nk'uko kanseri yawe isubiza, ingaruka zikubaho, na gahunda yawe yose yo kuvurwa.
Kubera kanseri y'ibere yo mu ntangiriro, kuvurwa bikunze kumara umwaka umwe. Kubera kanseri yateye imbere, ushobora gukomeza igihe cyose umuti ufasha kugenzura indwara yawe kandi ukawihanganira neza.
Ubusanzwe ushobora guhabwa inkingo nyinshi nkanwa trastuzumab-pkrb, ariko ni ngombwa kubiganiraho n'ikipe yawe y'ubuvuzi mbere. Bashobora kugusaba guteganya inkingo hafi y'imiti yawe cyangwa kwirinda inkingo zifite ubuzima mu gihe uvurwa.
Muganga wawe azatekereza uko umeze ku giti cyawe n'ubuzima bwawe bw'ubu mu gihe atanga inama ku bijyanye n'inkingo. Ibi ni ngombwa cyane ku nkingo z'ibicurane by'igihembwe n'inkingo za COVID-19.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.